Search Results 11041-11050 of 37143 for oral

  1. Diarrhea When to see a doctor - Mayo Clinic

    However, severe diarrhea (greater than 10 bowel movements a day or diarrhea where fluid losses are significantly greater than oral intake) can cause ...

  2. Coronary Artery Disease Clinical Trials - Mayo Clinic Research

    ... oral daily rapamycin (0.5, 1, and 2mg) dose for the duration of CR. Baseline and follow-up data will be collected for age-associated impairment (AAI): ...

  3. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

  4. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

  5. Publications - Brian D. Rinker, M.D. - Mayo Clinic

    The effect of saliva and oral intake on the tensile properties of sutures: an experimental study. Ann Plast Surg. 2007 Mar; 58 (3):268-72. View PubMed; Habash ...

  6. Publications - Shannon M. Dunlay, M.D., M.S. - Mayo Clinic

    Safety and Efficacy of Oral Anticoagulants for Atrial Fibrillation in Patients After Bariatric Surgery. Am J Cardiol. 2020 Dec 1; 136:76-80 Epub 2020 Sept ...

  7. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

    Hormonal contraception (oral, implant, injection, ring, or patch) for at least 12 weeks before the Screening Visit. 4. If male, subjects must agree to ...

  8. Medical Research & Education - Mayo Clinic News Network

    Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk Information ...

  9. Publications - Afsaneh Alavi, M.D. - Mayo Clinic

    Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized ...

  10. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...